ABCA1 p.Ala937Val
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21697542
[PubMed]
Lee JY et al: "ABCA1 increases extracellular ATP to mediate cholesterol efflux to ApoA-I."
No.
Sentence
Comment
11
Importantly, a dysfunctional ABCA1 mutant (A937V), when expressed similarly as wild-type ABCA1, is unable to raise extracellular ATP concentration, which suggests a casual relationship between functional ABCA1 and elevated extracellular ATP.
X
ABCA1 p.Ala937Val 21697542:11:43
status: NEW61 BHK-A937V cells contain an ABCA1 gene insert carrying a single nucleotide A to V mutation.
X
ABCA1 p.Ala937Val 21697542:61:4
status: NEW116 RESULTS To determine whether functional ABCA1 influences extracellular ATP levels, we analyzed ATP concentrations in the medium of BHK-ABCA1 cells and compared them with the medium collected from Mock-BHK or BHK-A937V cells.
X
ABCA1 p.Ala937Val 21697542:116:60
status: NEWX
ABCA1 p.Ala937Val 21697542:116:212
status: NEW118 Specifically, BHK-ABCA1 cells carry the wild-type (WT) ABCA1 insert, whereas BHK-A937V cells carry an alanine to valine mutant within the first nucleotide-binding domain of the transporter (34).
X
ABCA1 p.Ala937Val 21697542:118:81
status: NEW120 Once induced with mifepristone overnight, BHK-ABCA1 and BHK-A937V cells express ABCA1 or ABCA1A937V , respectively, at comparable levels but not BHK-Mock cells (Fig. 1A, right 3 lanes).
X
ABCA1 p.Ala937Val 21697542:120:60
status: NEW145 Most interestingly, mifepristone does not alter the extracellular ATP concentration in BHK-A937V cells (Fig. 1C), although ABCA1A937V is similarly expressed as WT ABCA1.
X
ABCA1 p.Ala937Val 21697542:145:91
status: NEW7 Importantly, a dysfunctional ABCA1 mutant (A937V), when expressed similarly as wild-type ABCA1, is unable to raise extracellular ATP concentration, which suggests a casual relationship between functional ABCA1 and elevated extracellular ATP.
X
ABCA1 p.Ala937Val 21697542:7:43
status: NEW58 BHK-A937V cells contain an ABCA1 gene insert carrying a single nucleotide A to V mutation.
X
ABCA1 p.Ala937Val 21697542:58:4
status: NEW112 RESULTS To determine whether functional ABCA1 influences extracellular ATP levels, we analyzed ATP concentrations in the medium of BHK-ABCA1 cells and compared them with the medium collected from Mock-BHK or BHK-A937V cells.
X
ABCA1 p.Ala937Val 21697542:112:212
status: NEW114 Specifically, BHK-ABCA1 cells carry the wild-type (WT) ABCA1 insert, whereas BHK-A937V cells carry an alanine to valine mutant within the first nucleotide-binding domain of the transporter (34).
X
ABCA1 p.Ala937Val 21697542:114:81
status: NEW140 Most interestingly, mifepristone does not alter the extracellular ATP concentration in BHK-A937V cells (Fig. 1C), although ABCA1A937V is similarly expressed as WT ABCA1.
X
ABCA1 p.Ala937Val 21697542:140:91
status: NEW
PMID: 18941142
[PubMed]
Nandi S et al: "ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity."
No.
Sentence
Comment
5
For instance, a nucleotide binding domain mutation in ABCA1 (A937V) that impaired HDL generation also abolished microparticle release.
X
ABCA1 p.Ala937Val 18941142:5:61
status: NEW151 A: 3 H-cholesterol labeled BHK-mock, ABCA1, ABCA1-A937V cells were induced for 20 h and incubated with DMEM without apoA-I for 4 h. B: 3 H-cholesterol labeled BHK-mock and ABCA1 were induced and incubated with DMEM with or without 50 mM PKI.
X
ABCA1 p.Ala937Val 18941142:151:50
status: NEW
PMID: 18776170
[PubMed]
Vaughan AM et al: "ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation."
No.
Sentence
Comment
49
the first extracellular loop (V399A, R587W, W590S, and Q597R), two were in the second extracellular loop (C1477R and I1517R), and one was in the Walker A motif of the first nucleotide binding domain (A937V, NBD1) (Fig. 1).
X
ABCA1 p.Ala937Val 18776170:49:200
status: NEW50 We also generated an artificial mutation in the Walker A motif of NBD2 (A1950V) that corresponds to the A937V mutation in NBD1.
X
ABCA1 p.Ala937Val 18776170:50:104
status: NEW93 The two most severe mutations, which reduced apoA-I-mediated lipid efflux to less than 20% of normal, were located in the first extracellular loop (Q597R) and the ATP binding site (A937V).
X
ABCA1 p.Ala937Val 18776170:93:181
status: NEW92 The two most severe mutations, which reduced apoA-I-mediated lipid efflux to less than 20% of normal, were located in the first extracellular loop (Q597R) and the ATP binding site (A937V).
X
ABCA1 p.Ala937Val 18776170:92:181
status: NEW
PMID: 17409096
[PubMed]
Nagao K et al: "Enhanced apoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells."
No.
Sentence
Comment
165
The result by Landry et al., showing that a non-functional ABCA1 with mutation in the ATP-binding domain A937V fails to redistribute cholesterol, may support the latter model.
X
ABCA1 p.Ala937Val 17409096:165:105
status: NEW163 The result by Landry et al., showing that a non-functional ABCA1 with mutation in the ATP-binding domain A937V fails to redistribute cholesterol, may support the latter model.
X
ABCA1 p.Ala937Val 17409096:163:105
status: NEW
PMID: 16984907
[PubMed]
Landry YD et al: "ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions."
No.
Sentence
Comment
3
Cholesterol content in the plasma membraneis,however,notaltered.Moreover,weprovideevidence that a non-functional ABCA1 with mutation in an ATP-binding domain,A937V,failstoredistributecholesterol,sphingomyelin,or caveolin.
X
ABCA1 p.Ala937Val 16984907:3:158
status: NEW4 A937V also fails to influence Akt activation.
X
ABCA1 p.Ala937Val 16984907:4:0
status: NEW110 Cy3-Transferrin Labeling of EYFP-Caveolin-1-transfected Cells-Mock, ABCA1, and A937V mutant cells were grown in 35-mm glass-bottom dishes and transfected with EYFP-caveolin-1 as described above.
X
ABCA1 p.Ala937Val 16984907:110:79
status: NEW118 Mock, ABCA1, and A937V mutant cells were grown to 80% confluence in 20-cm plates (five per cell line), and incubated in DMEM with 1 mg/ml BSA and 10 nM mifepristone for 18 h to induce ABCA1 expression.
X
ABCA1 p.Ala937Val 16984907:118:17
status: NEW132 Subcellular [3 H]Cholesterol Distribution-Mock, ABCA1, and A937V mutant cells were grown to 80% confluence in 20-cm plates (two for each cell line).
X
ABCA1 p.Ala937Val 16984907:132:59
status: NEW145 Briefly, mock, ABCA1, and A937V mutant cells were grown to 80% confluence in 20-cm plates.
X
ABCA1 p.Ala937Val 16984907:145:26
status: NEW168 A, ABCA1 expression in Mock, ABCA1 and ABCA1 mutant, A937V, before (lane 1-3) and after over night incubation with 10 nM mifepristone (lane 4-12).
X
ABCA1 p.Ala937Val 16984907:168:53
status: NEW191 ABCA1-expressing cells, however, seemed to have slightly less cholesterol in the endoplasmic reticulum (fractions 9 and 10) than Mock or A937V cells, which may reflect higher cholesterol mobility from internal membranes to the plasma membrane upon ABCA1 expression.
X
ABCA1 p.Ala937Val 16984907:191:137
status: NEW193 We also included a BHK cell line that expresses a mutant form of ABCA1 (A937V) upon mifepristone induction.
X
ABCA1 p.Ala937Val 16984907:193:72
status: NEW195 Cholesterol distribution in A937V-expressing cells was also identical to that of wt ABCA1-expressing or Mock cells (Fig. 2, FIGURE 2.
X
ABCA1 p.Ala937Val 16984907:195:28
status: NEW197 A, ABCA1 distribution in Mock, ABCA1, and A937V cells.
X
ABCA1 p.Ala937Val 16984907:197:42
status: NEW201 B, Mock, ABCA1, and A937V cells were stained with filipin, and fluorescent images were taken under identical conditions.
X
ABCA1 p.Ala937Val 16984907:201:20
status: NEW207 A937V contains a naturally occurring mutation in its first ATP-binding domain and is not able to mediate cholesterol efflux (Fig. 1B).
X
ABCA1 p.Ala937Val 16984907:207:0
status: NEW210 Mock, ABCA1, and A937V cells were treated with ice-cold Triton X-100 (1%) for 30 min.
X
ABCA1 p.Ala937Val 16984907:210:17
status: NEW220 To address this, we used BHK cells expressing A937V.
X
ABCA1 p.Ala937Val 16984907:220:46
status: NEW221 The cold Triton X-100-extractable cholesterol fraction in A937V-expressing cells was identical to that in Mock cells (Fig. 3, A and B), indicating that cholesterol redistribution from raft to non-rafts requires functional ABCA1 protein.
X
ABCA1 p.Ala937Val 16984907:221:46
status: NEWX
ABCA1 p.Ala937Val 16984907:221:58
status: NEW226 Once again, the A937V mutant failed to redistribute [3 H]sphingomyelin, consistent with its incapability to redistribute cholesterol in these cells.
X
ABCA1 p.Ala937Val 16984907:226:16
status: NEW238 We transiently transfected Mock, ABCA1, and A937V cells with YFP-caveolin.
X
ABCA1 p.Ala937Val 16984907:238:44
status: NEW242 BHK cells induced to express either empty vector (Mock), ABCA1 (ABCA1), or ABCA1 mutant A937V (A937V) cells were incubated with mifepristone overnight and subjected to 1% cold Triton X-100 extraction for 30 min on ice.
X
ABCA1 p.Ala937Val 16984907:242:88
status: NEWX
ABCA1 p.Ala937Val 16984907:242:95
status: NEW248 C and D, Mock, ABCA1, and A937V cells were radiolabeled with 1 Ci/ml [3 H]choline for 24 h, chilled on ice for 30 min prior to 1% Triton X-100 extraction at 4 °C.
X
ABCA1 p.Ala937Val 16984907:248:26
status: NEW277 Furthermore, when we tested ABCA1 mutant A937V, we found that A937V was mainly localized on the plasma membrane and expressed at levels similar to wild-type ABCA1 (Fig. 6C).
X
ABCA1 p.Ala937Val 16984907:277:41
status: NEWX
ABCA1 p.Ala937Val 16984907:277:62
status: NEW279 YFP-caveolin in A937V cells was mostly clustered, identical to that in Mock cells.
X
ABCA1 p.Ala937Val 16984907:279:16
status: NEW280 This is consistent with our observations presented above that A937V is defective in redistributing rafts (Fig. 3).
X
ABCA1 p.Ala937Val 16984907:280:62
status: NEW291 We therefore performed experiments using a non- detergent-based method, Optiprep gradient floatation, on Mock, ABCA1, and A937V cells (Fig. 7A).
X
ABCA1 p.Ala937Val 16984907:291:120
status: NEW293 A minor portion of caveolin (ϳ5%) was found in fractions 7-9, co-localizing with clathrin, a non-raft maker, in Mock and A937V cells.
X
ABCA1 p.Ala937Val 16984907:293:127
status: NEW294 However, there was much more caveolin in the non-raft fractions (20%) in ABCA1 cells than either Mock or A937V cells (Fig. 7B).
X
ABCA1 p.Ala937Val 16984907:294:105
status: NEW295 There was no significant difference between Mock and A937V cells.
X
ABCA1 p.Ala937Val 16984907:295:53
status: NEW300 BHK cells expressing either wt ABCA1 or A937V were transfected with YFP-caveolin and immunostained for ABCA1.
X
ABCA1 p.Ala937Val 16984907:300:40
status: NEW305 Mock, ABCA1, and A937V cells were induced overnight with mifepristone, and membrane fractions were isolated as described under "Materials and Methods."
X
ABCA1 p.Ala937Val 16984907:305:17
status: NEW307 B, the Western blots were scanned and analyzed for Mock, ABCA1, and A937V cells.
X
ABCA1 p.Ala937Val 16984907:307:68
status: NEW313 Expression of A937V once again does not alter Akt activation (Fig. 8A).
X
ABCA1 p.Ala937Val 16984907:313:14
status: NEW330 Mock, ABCA1, and A937V cells were induced and serum-starved overnight before EGF treatment.
X
ABCA1 p.Ala937Val 16984907:330:17
status: NEW358 Most importantly, we found that a functional nucleotide-binding domain in ABCA1 is required for non-raft expansion, because the A937V mutant failed to induce any cholesterol, sphingomyelin, or caveolin redistribution.
X
ABCA1 p.Ala937Val 16984907:358:128
status: NEW359 A937V mutant also failed to impair Akt phosphorylation.
X
ABCA1 p.Ala937Val 16984907:359:0
status: NEW378 Our observations with the A937V mutant seem to support this later notion.
X
ABCA1 p.Ala937Val 16984907:378:26
status: NEW192 ABCA1-expressing cells, however, seemed to have slightly less cholesterol in the endoplasmic reticulum (fractions 9 and 10) than Mock or A937V cells, which may reflect higher cholesterol mobility from internal membranes to the plasma membrane upon ABCA1 expression.
X
ABCA1 p.Ala937Val 16984907:192:137
status: NEW194 We also included a BHK cell line that expresses a mutant form of ABCA1 (A937V) upon mifepristone induction.
X
ABCA1 p.Ala937Val 16984907:194:72
status: NEW196 Cholesterol distribution in A937V-expressing cells was also identical to that of wt ABCA1-expressing or Mock cells (Fig. 2, FIGURE 2.
X
ABCA1 p.Ala937Val 16984907:196:28
status: NEW198 A, ABCA1 distribution in Mock, ABCA1, and A937V cells.
X
ABCA1 p.Ala937Val 16984907:198:42
status: NEW202 B, Mock, ABCA1, and A937V cells were stained with filipin, and fluorescent images were taken under identical conditions.
X
ABCA1 p.Ala937Val 16984907:202:20
status: NEW208 A937V contains a naturally occurring mutation in its first ATP-binding domain and is not able to mediate cholesterol efflux (Fig. 1B).
X
ABCA1 p.Ala937Val 16984907:208:0
status: NEW211 Mock, ABCA1, and A937V cells were treated with ice-cold Triton X-100 (1%) for 30 min.
X
ABCA1 p.Ala937Val 16984907:211:17
status: NEW222 The cold Triton X-100-extractable cholesterol fraction in A937V-expressing cells was identical to that in Mock cells (Fig. 3, A and B), indicating that cholesterol redistribution from raft to non-rafts requires functional ABCA1 protein.
X
ABCA1 p.Ala937Val 16984907:222:58
status: NEW227 Once again, the A937V mutant failed to redistribute [3 H]sphingomyelin, consistent with its incapability to redistribute cholesterol in these cells.
X
ABCA1 p.Ala937Val 16984907:227:16
status: NEW239 We transiently transfected Mock, ABCA1, and A937V cells with YFP-caveolin.
X
ABCA1 p.Ala937Val 16984907:239:44
status: NEW243 BHK cells induced to express either empty vector (Mock), ABCA1 (ABCA1), or ABCA1 mutant A937V (A937V) cells were incubated with mifepristone overnight and subjected to 1% cold Triton X-100 extraction for 30 min on ice.
X
ABCA1 p.Ala937Val 16984907:243:88
status: NEWX
ABCA1 p.Ala937Val 16984907:243:95
status: NEW249 C and D, Mock, ABCA1, and A937V cells were radiolabeled with 1 òe;Ci/ml [3 H]choline for 24 h, chilled on ice for 30 min prior to 1% Triton X-100 extraction at 4 &#b0;C.
X
ABCA1 p.Ala937Val 16984907:249:26
status: NEW377 Our observations with the A937V mutant seem to support this later notion.
X
ABCA1 p.Ala937Val 16984907:377:26
status: NEW
PMID: 16704350
[PubMed]
Brunham LR et al: "Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis."
No.
Sentence
Comment
555
Since a complete loss of function allele would be expected to result in a 50% reduction in HDL levels, a greater than 50% reduction in HDL is most likely explained by a dominant negative allele, in which TABLE 3 Patient phenotypes associated with heterozygous ABCA1 mutations Mutation HDL (mmol/L) HDL (% of control) Number of patients M1091T 0.48 ± 0.5 30 ± 30 4 G1216V 0.50 40 1 R2144X 0.56 ± 0.2 41 ± 18 12 R282X 0.52 41 1 R909X 0.59 ± 0.3 42 ± 19 5 K776N 0.55 ± 0.1 47 ± 5 2 R587W 0.61 ± 0.1 47 ± 8 7 S364C 0.60 48 1 P1065S 0.80 51 1 c-ter deletion 0.75 53 1 N1800H - 56.5 33 P85L 0.72 ± 0.4 57 ± 33 5 Del693L 0.79 ± 0.2 57 ± 15 8 D1289N 0.80 ± 0.1 59 ± 12 4 R2081W 0.80 ± 0.1 59 ± 12 4 2203X 0.80 ± 0.2 59 ± 20 4 DelED1893,4 0.77 ± 0.2 59 ± 18 8 2145X 0.82 ± 0.1 59 ± 9 4 A1046D 0.70 ± 0.1 60 ± 8 2 Q597R 0.82 ± 0.1 60 ± 5 5 C1477R 0.82 ± 0.2 61 ± 15 9 IVS25 + 1G > C 0.78 ± 0.1 62 ± 12 4 D1099Y 0.83 ± 0.3 63 ± 21 5 1552X 1.00 64 1 F2009S 0.82 ± 0.2 64 ± 19 6 R587W 0.86 ± 0.1 65 ± 17 2 R1068H 0.90 ± 0.3 67 ± 26 9 N935S 1.00 ± 0.3 74 ± 16 7 T929I 1.01 ± 0.2 76 ± 7 8 1284X 1.11 ± 0.2 83 ± 14 5 A937V 1.15 ± 0.6 85 ± 28 2 R1680W 1.22 ± 0.2 87 ± 17 3 635X 1.24 ± 0.5 90 ± 32 7 W590S 1.32 ± 0.6 103 ± 46 15 the mutant protein actually interferes with the activity of the remaining wild-type protein.
X
ABCA1 p.Ala937Val 16704350:555:1334
status: NEW
PMID: 16429166
[PubMed]
Brunham LR et al: "Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene."
No.
Sentence
Comment
48
This SNP has been reported to be associated with decreased HDL cholesterol and increased severity of atherosclerosis in Table 1. subPSEC Scores and Probability of Functional Impairment (Pdeleterious) for ABCA1 Mutations and SNPs Mutations SNPs Variant SubPSEC Pdeleterious Variant subPSEC Pdeleterious P85L À4.62 0.83 R219K À0.57 0.08 H160F À2.79 0.45 V399A À2.26 0.32 R230C À4.27 0.78 V771M À2.86 0.46 A255T À1.81 0.23 T774P À1.99 0.27 E284K À2.34 0.34 K776N À3.53 0.63 Y482C À4.21 0.77 V825I À1.06 0.13 R587W À6.04 0.95 I883M À1.38 0.17 W590S À5.19 0.9 E1172D À1.96 0.26 W590L À4.48 0.82 R1587K À0.58 0.08 Q597R À7.15 0.98 S1731C À4.21 0.77 T929I À4.29 0.78 N935H À8.54 1 N935S À7.53 0.99 A937V À6.6 0.97 A1046D À7.52 0.99 M1091T À3.56 0.64 D1099Y À6.09 0.96 D1289N À2.48 0.37 L1379F À3.81 0.69 C1477R À5.44 0.92 S1506L À5.17 0.9 N1611D À5.69 0.94 R1680W À6.02 0.95 V1704D À3.21 0.55 N1800H À4.23 0.77 R1901S À5.06 0.89 F2009S À2.73 0.43 R2081W À8.08 0.99 P2150L À2.88 0.47 Q2196H À2.74 0.43 DOI: 10.1371/journal.pgen.0010083.t001 PLoS Genetics | www.plosgenetics.org December 2005 | Volume 1 | Issue 6 | e83 0740 Accurate Prediction of ABCA1 Variants Synopsis A major goal of human genetics research is to understand how genetic variation leads to differences in the function of genes.
X
ABCA1 p.Ala937Val 16429166:48:691
status: NEWX
ABCA1 p.Ala937Val 16429166:48:806
status: NEW
PMID: 12763760
[PubMed]
Singaraja RR et al: "Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene."
No.
Sentence
Comment
83
TABLE 2. Conservation of Amino Acid Residues Mutated in Humans Mutation H. sapiens M. musculus G. gallus D. melanogaster C. elegans P85L P P P ⅐ ⅐ ⅐ P R230C R R R P G A255T A A S ⅐ ⅐ ⅐ ⅐ ⅐ ⅐ R587W R R R ⅐ ⅐ ⅐ ⅐ ⅐ ⅐ W590S W W W R Q Q597R Q Q Q Q Q ⌬L693 L L L L L T929I T T T T T N935S/H N N N N N A937V A A A A A A1046D A A A A A M1091T M M M M M D1099Y D D D D D D1289L/N D D D D D C1477R C C C ⅐ ⅐ ⅐ ⅐ ⅐ ⅐ S1506L S S S ⅐ ⅐ ⅐ ⅐ ⅐ ⅐ N1611D N N N N S R1680W R R R R R N1800H N N N A W F2009S F F F I M R2081W R R R R R P2150L P P P R N ⌬E1893 E E E D S ⌬D1894 D D D D D Twenty-three of 24 (95.83%) amino acids affected by mutations are conserved with G. gallus, reflecting the functional importance of these residues.
X
ABCA1 p.Ala937Val 12763760:83:409
status: NEW114 Patients homozygous for the mutations A255T and R1680W show HDL-C levels that are greater than 10% of age-and sex-matched population controls.
X
ABCA1 p.Ala937Val 12763760:114:102
status: NEW122 This is indeed the case in heterozygous patients harboring mutations A255T, W590S, T929I, R1680W, and A937V, who all show HDL-C levelsϾ75% of normal age-and sex-matched controls.
X
ABCA1 p.Ala937Val 12763760:122:102
status: NEW75 TABLE 2. Conservation of Amino Acid Residues Mutated in Humans Mutation H. sapiens M. musculus G. gallus D. melanogaster C. elegans P85L P P P ዼ ዼ ዼ P R230C R R R P G A255T A A S ዼ ዼ ዼ ዼ ዼ ዼ R587W R R R ዼ ዼ ዼ ዼ ዼ ዼ W590S W W W R Q Q597R Q Q Q Q Q èc;L693 L L L L L T929I T T T T T N935S/H N N N N N A937V A A A A A A1046D A A A A A M1091T M M M M M D1099Y D D D D D D1289L/N D D D D D C1477R C C C ዼ ዼ ዼ ዼ ዼ ዼ S1506L S S S ዼ ዼ ዼ ዼ ዼ ዼ N1611D N N N N S R1680W R R R R R N1800H N N N A W F2009S F F F I M R2081W R R R R R P2150L P P P R N èc;E1893 E E E D S èc;D1894 D D D D D Twenty-three of 24 (95.83%) amino acids affected by mutations are conserved with G. gallus, reflecting the functional importance of these residues.
X
ABCA1 p.Ala937Val 12763760:75:393
status: NEW
No.
Sentence
Comment
66
TD 1591 T/C 11 V399A extracellular [68] TD 1979 (110bpAlu Ins) 12 truncated truncation [60] TD/FHA 2154 C/T 14 R587W extracellular [67,69] TD 2164 G/C 14 W590S extracellular [61] TD 2185 A/G 14 Q597R extracellular [59,67] TD 2219 G/del 14 truncated, 635X truncated [60,61] FHA 2472-2474 3bp del 15 Del L693 TM domain #3 [59] phosphorylation 2706 G/A 16 V771M extracellular [68] 2715 A/C 16 T774P extracellular [68] 2723 G/C 16 K776N extracellular [68] 2868 G/A 17 V825I TM domain #6 [67,68] TD/FHA 3044 A/G 18 I883M cytoplasmic [68] phosphorylat site FHA 3120 C/T 19 R909X truncation [63,71] TD 3181 C/T 19 T929I cytoplasmic [62] TD 3199 A/G 19 N935S Walker A [61] TD 3205 C/T 19 A937V Walker A [61] TD 3532 C/A 22 A1046D cytoplasmic, Walker A/B [70] FHA 3667 T/C 23 M1091T cytoplasmic [63] 3690 G/T 23 D1099Y cytoplasmic [9] TD 3738 2bp del 23 1145X truncation [66] FHA 3911 G/C 24 E1172D linker/cytoplasmic [68] FHA 4242 4bp del 27 1297X truncated [64] TD 4260 G/A 27 D1289N linker cytoplasm [64,65] TD 4824 T/C 31 C1477R extracellular [59] TD 4912 C/T 32 S1506L extracellular loop #2 [71] TD 5025 ins A 34 A1544S?1552X truncation [70] 5059 T/C 34 I1555T extracellular loop #2 [67] 5155 G/A 35 R1587K extracellular loop #2 [68] FHA 5226 A/G 36 N1611D extracellular loop #2 [75..] 5338 T/C 36 L1648P extracellular loop #2 [67] TD 5443 C/T 37 R1680W cytoplasmic [74.]
X
ABCA1 p.Ala937Val 12840658:66:680
status: NEW
PMID: 12111381
[PubMed]
Guo Z et al: "Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 ( ABCA1) gene in Japanese patients with Tangier disease."
No.
Sentence
Comment
86
The Ala937Val mutation in Walker A motif (Bodzioch et al. 1999) and Ala1046Asp near Walker B motif (Wang et al. 2000) of the first NBF have been reported.
X
ABCA1 p.Ala937Val 12111381:86:4
status: NEW
PMID: 23055522
[PubMed]
Ma L et al: "ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation."
No.
Sentence
Comment
106
A nonfunctional ABCA1 mutant, A937V, failed to increase p-CREB despite being expressed at a similar level as WT ABCA1 (Fig. 2A) with correct targeting to the plasma membrane (21).
X
ABCA1 p.Ala937Val 23055522:106:30
status: NEW
PMID: 25415591
[PubMed]
Dong F et al: "Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1."
No.
Sentence
Comment
64
BHK cells stably expressing an mifepristone-inducible vector with human ABCA1 (ABCA1) or mutant A937V ABCA1 (A937V) gene insert were prepared as described previously [26].
X
ABCA1 p.Ala937Val 25415591:64:96
status: NEWX
ABCA1 p.Ala937Val 25415591:64:109
status: NEW121 It has little effect on BHK cells with no ABCA1 expression (data not shown) or BHK cells expressing a dysfunctional mutant form of ABCA1 (A937V) (Fig. 1 C).
X
ABCA1 p.Ala937Val 25415591:121:138
status: NEW150 C) BHK-ABCA1 and BHK-A937V cells were induced with mifepristone (10 nM) overnight.
X
ABCA1 p.Ala937Val 25415591:150:21
status: NEW